Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 2Terminated 1

Sponsor Class

INDUSTRY 5OTHER 3NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 4Thoracic 3Head & Neck 3Tumor-Agnostic 2Gastrointestinal 2Other hematologic neoplasm 1Myeloid 1CNS 1Breast 1

Conditions

Small Cell Lung Carcinoma 2Lung Neoplasms 1

Interventions

Carboplatin 510Cisplatin 410Pemetrexed 400Radiotherapy 285Docetaxel 244Paclitaxel 227pembrolizumab 226Gemcitabine 198Drug Therapy 191Bevacizumab 190Erlotinib Hydrochloride 189Radiosurgery 177Nivolumab 168Etoposide 155durvalumab 154osimertinib 126atezolizumab 109Gefitinib 96Blood Specimen Collection 93Magnetic Resonance Spectroscopy 91Vinorelbine 90anlotinib 88Surgical Procedures, Operative 85Ipilimumab 62Immunotherapy 62Surveys and Questionnaires 60sintilimab 59Specimen Handling 59tislelizumab 58Irinotecan 57

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × adavosertib × Thoracic × Clear all
NCT02513563 2026-02-19

AZD1775 Plus Carboplatin-Paclitaxel in Squamous Cell Lung Cancer

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Completed
42 enrolled 12 charts
Thoracic

Lung Neoplasms

NCT02593019 2021-03-19

Phase II, Single-arm Study of AZD1775 Monotherapy in Relapsed Small Cell Lung Cancer Patients

Samsung Medical Center

Phase 2 Completed
24 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT02688907 2018-09-20

Phase II, Single-arm Study of AZD1775 Monotherapy in Relapsed Small Cell Lung Cancer Patients With MYC Family Amplification or CDKN2A Mutation Combined With TP53 Mutation

Samsung Medical Center

Phase 2 Terminated
7 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡